Whilst ePI brings with it a whole host of benefits, certain barriers such as limited internet access or varying levels of ...

At the LSX (Life Sciences Executive) World Congress in Boston, leaders in biotech, healthtech, and medtech will gather to ...

The life sciences sector across Europe has remained remarkably resilient in recent years, with record levels of growth and ...

Almost half of UK doctors would not use generative artificial intelligence (GenAI) to treat patients, although there is ...

In the new SCALE Kids study, which has been published in the New England Journal of Medicine, a daily 3mg dose of Saxenda ...

As these teams mature, establishing robust processes, enhancing SRM for contract negotiation, and improving internal ...

Uncover mitochondrial dysfunction in diverse patient populations and develop higher efficacy targeting tactics for primary ...

There was a 16% rate of hearing impairment with veligrotug – a recognised side effect of anti-IGF-1R therapy – with a 5.5% ...

Roivant's latest biotech company launch – Pulmovant – has made its debut with a plan to develop a respiratory drug licensed ...

But Harris went beyond boasting about the administration's accomplishments (and thankfully managed to avoid claiming to have ...

Day One will kick off with a couple of sessions on the investing landscape, including one featuring speakers from Google and Eli Lilly.

Join 100+ industry leaders, scientists, and clinicians at the premier, end-to-end, 8th Complement-Based Drug Development Summit to shape the future of complement-targeted therapies. Across 3 days of ...